• Cellvizio®
    • Overview
    • Education
    • Economics
    • Indications
      • Gastroenterology
        • Barrett’s Esophagus
        • Pancreatic Cysts
        • Gastric Disease
        • Inflammatory Bowel Diseases
        • Irritable Bowel Syndrome – Food Intolerance
        • Bilio-Pancreatic Strictures
        • Colorectal Lesions
      • Pulmonology
        • Lung Nodules
        • Lung Transplant
      • Urology
  • Investors
    • Overview
    • Events and Presentations
    • Financials
    • Governance
  • About Us
    • Our Story
    • Team
      • Board of Directors
      • Leadership Team
    • Join Us
    • Commercial network
  • Newsroom
    • News
    • Events
    • Press Coverage
  • INT
    • US
    • FR
Mauna Kea Technologies Extends Its Financial Horizon Beyond the Observation Period of the Safeguard Procedure 

Mauna Kea Technologies Extends Its Financial Horizon Beyond the Observation Period of the Safeguard Procedure 

by Elizabeth | Jul 10, 2025 | News

Bridge financing through the issuance of convertible bonds to Vester Finance and European investors for €1.8m  Immediate receipt of the entire financing upon signing  Cash runway extended to November 2025, providing sufficient financial visibility to...
Mauna Kea Technologies Extends Its Financial Horizon Beyond the Observation Period of the Safeguard Procedure 

Mauna Kea Technologies Reaches Key Milestone in its Safeguard Procedure 

by Elizabeth | Jul 10, 2025 | News

Structuring of financing in progress to secure the safeguard period and support long-term development plan  Authorization to implement the classes of affected parties proceeding, paving the way to the Company’s debt restructuring  Paris and Boston,...
‘Never a Dull Moment’ Dr. Ravi Prakash Keeps Patients Front and Center

‘Never a Dull Moment’ Dr. Ravi Prakash Keeps Patients Front and Center

by Elizabeth | Jun 11, 2025 | Press Coverage

Dr. Ravi Prakash of Advocate Good Samaritan Hospital is a leader in gastroenterology and a valued member of the Cellvizio community. Dr. Prakash champions the adoption of advanced medical technology, understanding that modern tools are essential to...
Mauna Kea Technologies Extends Its Financial Horizon Beyond the Observation Period of the Safeguard Procedure 

Mauna Kea Technologies announces results of its Combined General Meeting of June 5, 2025 

by Elizabeth | Jun 5, 2025 | News

All the resolutions proposed by the Board of Directors were adopted  Paris and Boston, June 5, 2025 – 5:45 p.m. CEST – Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser...
Mauna Kea Technologies Announces Major AI Breakthrough with Cellvizio in Pancreatic Cystic Lesion Risk Stratification 

Mauna Kea Technologies Announces Major AI Breakthrough with Cellvizio in Pancreatic Cystic Lesion Risk Stratification 

by Elizabeth | Jun 2, 2025 | News

Cellvizio® technology combined with AI outperforms human experts in pancreatic cyst risk stratification, a major breakthrough for patient management  Results build on new CLIMB study data recently presented at Digestive Disease Week® (DDW)1 confirming Cellvizio®’s...
« Older Entries
Next Entries »

Articles récents

  • See Beyond the Surface: How Cellvizio® Redefines Accuracy for Detecting and Treating Cancers
  • Mauna Kea Technologies Reports First Half 2025 Revenue 
  • Mauna Kea Technologies Enters Australian Market with Endotherapeutics Partnership 
  • Mauna Kea Technologies Strengthens its Leading Role in the AI-based Endomicroscopic Imaging Ecosystem with its 14th Patent Granted in the U.S. 
  • Mauna Kea Technologies Congratulates Stanford Health Care on Completing 100 Food Intolerance Cases with Cellvizio 

Commentaires récents

No comments to show.

Company Info

About Us

Join Us

Contact Us

Legal

Legal notice

Privacy policy

Cookies policy

Our websites

Cellvizio.net

cell-tolerance.com

Diagnosingbarretts.org

Diagnosingpancreaticcysts.org

Follow us

  • Follow
  • Follow
  • Follow
  • Follow
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}